BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 25858807)

  • 1. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy.
    Milan G; Romanello V; Pescatore F; Armani A; Paik JH; Frasson L; Seydel A; Zhao J; Abraham R; Goldberg AL; Blaauw B; DePinho RA; Sandri M
    Nat Commun; 2015 Apr; 6():6670. PubMed ID: 25858807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth.
    Lee D; Goldberg AL
    J Biol Chem; 2013 Oct; 288(42):30515-30526. PubMed ID: 24003218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
    Zhao J; Brault JJ; Schild A; Cao P; Sandri M; Schiaffino S; Lecker SH; Goldberg AL
    Cell Metab; 2007 Dec; 6(6):472-83. PubMed ID: 18054316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
    Tang H; Inoki K; Lee M; Wright E; Khuong A; Khuong A; Sugiarto S; Garner M; Paik J; DePinho RA; Goldman D; Guan KL; Shrager JB
    Sci Signal; 2014 Feb; 7(314):ra18. PubMed ID: 24570486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxO3 controls autophagy in skeletal muscle in vivo.
    Mammucari C; Milan G; Romanello V; Masiero E; Rudolf R; Del Piccolo P; Burden SJ; Di Lisi R; Sandri C; Zhao J; Goldberg AL; Schiaffino S; Sandri M
    Cell Metab; 2007 Dec; 6(6):458-71. PubMed ID: 18054315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy.
    O'Neill BT; Bhardwaj G; Penniman CM; Krumpoch MT; Suarez Beltran PA; Klaus K; Poro K; Li M; Pan H; Dreyfuss JM; Nair KS; Kahn CR
    Diabetes; 2019 Mar; 68(3):556-570. PubMed ID: 30523026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
    Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
    Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranslational modifications control FoxO3 activity during denervation.
    Bertaggia E; Coletto L; Sandri M
    Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
    Sandri M
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting.
    Oyabu M; Takigawa K; Mizutani S; Hatazawa Y; Fujita M; Ohira Y; Sugimoto T; Suzuki O; Tsuchiya K; Suganami T; Ogawa Y; Ishihara K; Miura S; Kamei Y
    FASEB J; 2022 Feb; 36(2):e22152. PubMed ID: 35061305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
    Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
    FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.
    Cid-Díaz T; Santos-Zas I; González-Sánchez J; Gurriarán-Rodríguez U; Mosteiro CS; Casabiell X; García-Caballero T; Mouly V; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):974-990. PubMed ID: 28675664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.
    Ratti F; Ramond F; Moncollin V; Simonet T; Milan G; Méjat A; Thomas JL; Streichenberger N; Gilquin B; Matthias P; Khochbin S; Sandri M; Schaeffer L
    J Biol Chem; 2015 Feb; 290(7):4215-24. PubMed ID: 25516595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle.
    Mammucari C; Schiaffino S; Sandri M
    Autophagy; 2008 May; 4(4):524-6. PubMed ID: 18367868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
    Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
    Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.